Search research articles
Contact Us
Filters
Showing results (201-210 of 227) with videos related to
Page
of 23
Sort By:
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
November 2, 2010
[The alliance of the parent, child and the nurse to challenge medical error]
D Davous, E Seigneur, A Auvrignon, et al.
British Journal of Cancer
|
November 15, 2000
Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer
J Y Pierga, E Mouret, V Diéras, et al.
Revue De Pneumologie Clinique
|
December 21, 2010
[Study KBP-2010-CPHG: inclusion of new cases of primary lung cancer diagnosed in general hospital pneumology departments between 1st January and 31 December 2010]
M Grivaux, C Locher, P Bombaron, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Real-world effectiveness of post-trastuzumab emtansine treatment for human epidermal growth factor receptor 2-positive metastatic breast cancer: a multicenter, matched cohort analysis from the Epidemiology Strategy and Medical Economics database (2008-2018)
C Courtinard, V Barbet, R Schiappa, et al.
The International Journal of Biological Markers
|
July 5, 2003
Medullary breast carcinoma: prognostic implications of p53 expression
R Dendale, A Vincent-Salomon, E Mouret-Fourme, et al.
Revue Des Maladies Respiratoires
|
June 22, 2006
[Cohort KBP-2000-CPHG: Evaluation of factors influencing survival in lung cancer]
F Blanchon, M Grivaux, M Zureik, et al.
British Journal of Cancer
|
October 20, 2011
High rate of extra-haematological toxicity compromises dose-dense sequential adjuvant chemotherapy for breast cancer
E Brain, C Levy, D Serin, et al.
ESMO Open
|
November 11, 2022
Real-world first-line treatment of patients with BRAF<sup>V600E</sup>-mutant metastatic colorectal cancer: the CAPSTAN CRC study
E Martinelli, C Cremolini, T Mazard, et al.
Journal Francais D'Ophtalmologie
|
July 6, 2000
[Optic neuropathy after proton-beam therapy for malignant choroidal melanoma]
A Meyer, C Lévy, J Blondel, et al.
Breast Cancer Research and Treatment
|
September 5, 2016
BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy
A S Hamy, I Bieche, J Lehmann-Che, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 227) with videos related to
Sort By:
Page
of 23
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
November 2, 2010
[The alliance of the parent, child and the nurse to challenge medical error]
D Davous, E Seigneur, A Auvrignon, et al.
British Journal of Cancer
|
November 15, 2000
Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer
J Y Pierga, E Mouret, V Diéras, et al.
Revue De Pneumologie Clinique
|
December 21, 2010
[Study KBP-2010-CPHG: inclusion of new cases of primary lung cancer diagnosed in general hospital pneumology departments between 1st January and 31 December 2010]
M Grivaux, C Locher, P Bombaron, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Real-world effectiveness of post-trastuzumab emtansine treatment for human epidermal growth factor receptor 2-positive metastatic breast cancer: a multicenter, matched cohort analysis from the Epidemiology Strategy and Medical Economics database (2008-2018)
C Courtinard, V Barbet, R Schiappa, et al.
The International Journal of Biological Markers
|
July 5, 2003
Medullary breast carcinoma: prognostic implications of p53 expression
R Dendale, A Vincent-Salomon, E Mouret-Fourme, et al.
Revue Des Maladies Respiratoires
|
June 22, 2006
[Cohort KBP-2000-CPHG: Evaluation of factors influencing survival in lung cancer]
F Blanchon, M Grivaux, M Zureik, et al.
British Journal of Cancer
|
October 20, 2011
High rate of extra-haematological toxicity compromises dose-dense sequential adjuvant chemotherapy for breast cancer
E Brain, C Levy, D Serin, et al.
ESMO Open
|
November 11, 2022
Real-world first-line treatment of patients with BRAF<sup>V600E</sup>-mutant metastatic colorectal cancer: the CAPSTAN CRC study
E Martinelli, C Cremolini, T Mazard, et al.
Journal Francais D'Ophtalmologie
|
July 6, 2000
[Optic neuropathy after proton-beam therapy for malignant choroidal melanoma]
A Meyer, C Lévy, J Blondel, et al.
Breast Cancer Research and Treatment
|
September 5, 2016
BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy
A S Hamy, I Bieche, J Lehmann-Che, et al.
Page
of 23